Metraipolis › archive › dc_0a839da372ef

Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41638252
DOI
10.1055/s-[numero omesso]
License (as archived)
solo-consultazione
Archived
2026-11-08T20:41:51.881Z
SHA-256 of the archived text
85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6
Stable URL of this page
https://metraipolis.com/documento/dc_0a839da372ef

How to cite

Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252 — Europe PMC (en), https://europepmc.org/article/MED/41638252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0a839da372ef (Metraipolis archive dc_0a839da372ef, sha256 85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6)
BibTeX
@misc{dc0a839da372ef,
  title = {Double-seronegative neuromyelitis optica: it is not possible to interrupt treatment after 10 years of stability — Europe PMC PMID:41638252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41638252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0a839da372ef; sha256 85033e09e8110f28cc706d30ebd9cc786895a52e677ad5038b9f0da294990ed6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41638252. Agents can read the archived copy with the MCP tool read_document.